Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer
- J. Al Shemaili,
- E. Mensah-Brown,
- K. Parekh,
- S. A. Thomas,
- S. Attoub,
- B. Hellman
- United Arab Emirates University,
- Uppsala University,
- Coastside Bio Resources
Research Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>Pancreatic cancer has a very poor prognosis. While gemcitabine is the mainstay of therapy and improves quality of life, it has little impact on survival. More effective treatments are desperately needed for this disease. Frondoside A is a triterpenoid glycoside isolated from the Atlantic sea cucumber, Cucumaria frondosa. Frondoside A potently inhibits pancreatic cancer cell growth and induces apoptosis in vitro and in vivo. The aim of the present study was to investigate whether frondoside A could enhance the anti-cancer effects of gemcitabine. Effects of frondoside A and gemcitabine alone and in combination on proliferation were investigated in two human pancreatic cancer cell lines, AsPC-1 and S2013. To investigate possible synergistic effects, combinations of low concentrations of the two drugs were used for a 72 h treatment period in vitro. Growth inhibition was significantly greater with the drug combinations than their additive effects. Combinations of frondoside A and gemcitabine were tested in vivo using the athymic mouse model. Xenografts of AsPC-1 and S2013 cells were allowed to form tumours prior to treatment with the drugs alone or in combination for 30 days. Tumours grew rapidly in placebo-treated animals. Tumour growth was significantly reduced in all treatment groups. At the lowest dose tested, gemcitabine (4 mg/kg/dose), combined with frondoside A (100 μg/kg/day) was significantly more effective than with either drug alone. To conclude: The present data suggest that combinations of frondoside A and gemcitabine may provide clinical benefit for patients with pancreatic cancer.</p>
Research Output Information
Output type
Research Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 1391-1398 (8 pages)Journal (Volume, Issue Number)
European Journal of Cancer (Volume 50, Issue 7)Publication milestones
- Published - 05/2014
Publication status
Published - 05/2014
ISSN
0959-8049Publication IDs
- Scopus: 84897389846
- PubMed: 24462376
Documents and links
Publication metrics
Metrics
SciVal
FWCI
0.94
PlumX, opens in new tab
Citation count
41
Captures
47
Sustainable Development Goals
- SDG 3 Good Health and Well
